GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » EPS (Basic)

Orchid Pharma (NSE:ORCHPHARMA) EPS (Basic) : ₹19.07 (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma EPS (Basic)?

Orchid Pharma's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ₹6.74. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹19.07.

Orchid Pharma's EPS (Diluted) for the three months ended in Mar. 2024 was ₹6.74. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹19.07.

Orchid Pharma's EPS without NRI for the three months ended in Mar. 2024 was ₹6.74. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 19.07.

During the past 12 months, Orchid Pharma's average EPS without NRIGrowth Rate was 460.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Orchid Pharma's highest 3-Year average EPS without NRI Growth Rate was 60.90% per year. The lowest was -13.80% per year. And the median was 17.70% per year.


Orchid Pharma EPS (Basic) Historical Data

The historical data trend for Orchid Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma EPS (Basic) Chart

Orchid Pharma Annual Data
Trend Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.75 -28.55 -0.48 11.35 19.06

Orchid Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.49 1.85 4.30 6.18 6.74

Orchid Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Orchid Pharma's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(921.665-0)/48.356
=19.06

Orchid Pharma's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(335.267-0)/50.632
=6.62

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹19.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orchid Pharma  (NSE:ORCHPHARMA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Orchid Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Orchid Pharma (NSE:ORCHPHARMA) Business Description

Traded in Other Exchanges
Address
313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines